Susquehanna International Group
SWTX

Susquehanna International Group’s SpringWorks Therapeutics SWTX Stock Holding History

Susquehanna International Group’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,173,900
Closed -$102M – 13829
2025
Q2 		$102M Buy
2,173,900
+570,400
+36% +$25.4M 0.01% 745
2025
Q1 		$70.8M Buy
1,603,500
+1,585,600
+8,858% +$73M 0.01% 827
2024
Q4 		$647K Sell
17,900
-6,900
-28% -$241K ﹤0.01% 8044
2024
Q3 		$795K Buy
24,800
+19,100
+335% +$714K ﹤0.01% 7364
2024
Q2 		$215K Sell
5,700
-175,500
-97% -$7.39M ﹤0.01% 10202
2024
Q1 		$8.92M Buy
181,200
+89,300
+97% +$4.13M ﹤0.01% 2764
2023
Q4 		$3.35M Buy
+91,900
New +$2.4M ﹤0.01% 4386
2023
Q2 		– Sell
-91,000
Closed -$2.34M – 13106
2023
Q1 		$2.34M Sell
91,000
-42,200
-32% -$1.23M ﹤0.01% 4808
2022
Q4 		$3.46M Buy
133,200
+25,500
+24% +$628K ﹤0.01% 3796
2022
Q3 		$3.07M Buy
107,700
+95,900
+813% +$2.75M ﹤0.01% 4042
2022
Q2 		$291K Sell
11,800
-181,600
-94% -$6.64M ﹤0.01% 9643
2022
Q1 		$10.9M Buy
+193,400
New +$11.1M ﹤0.01% 2442

Other funds holding SWTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's SWTX Position: Q3 2025 in Review

Susquehanna International Group sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 484,874 shares — an estimated $22.8M sold.

Susquehanna International Group first reported a position in SWTX in Q3 2019 and held it in 20 quarters. The position peaked at $27.5M in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

  • Susquehanna International Group reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 484,874 SpringWorks Therapeutics shares in Q3 2025, an estimated $22.8M.
  • Susquehanna International Group first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 20 quarters.
  • Susquehanna International Group's SpringWorks Therapeutics position peaked at $27.5M in Q1 2025.
  • 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.